U.S. Energy Services Stock News

If you are wondering whether Nabors Industries at around US$85.99 is offering value or just excitement, this breakdown is designed to help you separate price from underlying worth. The stock has moved sharply in recent periods, with returns of 7.7% over 7 days, 10.0% over 30 days, 55.2% year to date and 97.5% over 1 year. This is set against weaker 3 year and 5 year returns of 27.8% and 7.0% declines. Recent attention on Nabors Industries has focused on its position within the energy...

Cadence Design Systems (CDNS) extended its collaboration with NVIDIA, integrating NVIDIA’s accelerated computing stack more deeply into Cadence’s AI driven design and agentic AI tools across semiconductor, automotive, aerospace, energy and life sciences workflows. See our latest analysis for Cadence Design Systems. The latest collaboration news lands after a softer share price patch, with the 90-day share price return of 10.52% and year to date decline of 8.40% contrasting with a 1-year total...

Wondering whether AppFolio at around US$161.05 still makes sense as an investment, or if the recent price puts it out of your comfort zone on value. The stock has seen a 4.4% decline over the last 7 days, a 6.5% decline over 30 days, and a 30.1% decline year to date and over 1 year, while the 3 year and 5 year returns sit at 34.0% and 16.5% respectively. Recent coverage has focused on how the year to date and 1 year share price performance of 30.1% may be influencing investor sentiment...

Wondering if Levi Strauss shares at around US$18.43 are giving you genuine value or just the comfort of a familiar brand name? This article focuses squarely on what that current price might imply. The stock has seen a mixed return profile, with a 19.4% decline over the last 30 days and an 11.5% decline year to date, but a 17.8% gain over the past year and 14.5% annualized over three years. These figures can shape how investors think about both potential and risk. Recent coverage has focused...

Boeing contract puts fresh attention on Astronics stock Astronics (ATRO) has been selected by Boeing to supply fuel tank access doors for the 737 MAX program. The contract is tied directly to the company’s design engineering and vertically integrated manufacturing capabilities in Clackamas, Oregon. See our latest analysis for Astronics. Despite the Boeing announcement, Astronics’ share price has recently pulled back, with a 13.28% 1 month share price return and 3.42% 7 day share price return...

Earlier this year, Unum Group expanded its Unum Broker Connect integration with Employee Navigator to add automated billing and eligibility features, aiming to cut manual work and improve accuracy for brokers and employers managing benefits and leave. By automating eligibility data flows into Unum Total Leave, the company is positioning its benefits platform as a more integrated solution for employers grappling with increasingly complex leave management. We’ll now explore how this expanded...

LegalZoom.com (LZ) is back on investors’ radars after Barclays cut its rating to Underweight, flagging a relatively limited addressable market. This move coincides with recent earnings related and broader market pressures. See our latest analysis for LegalZoom.com. The share price has been under steady pressure, with a 1 day share price return of a 4.78% decline, a 30 day share price return of an 8.84% decline, and a 90 day share price return of a 40.32% decline. This leaves the latest close...

Why One Stop Systems is attracting fresh attention One Stop Systems (OSS) is back in focus after reporting full year 2025 results that shifted from a prior net loss to net income, alongside guidance calling for 20% to 25% revenue growth in 2026. See our latest analysis for One Stop Systems. Despite the strong 2025 results and new 2026 guidance, the recent 15.4% 7-day share price decline and 7.0% 30-day share price return contrast with a 231.1% 1-year total shareholder return, suggesting...

On 20 March 2026, Central Bancompany, Inc. (NasdaqGS:CBC) was added to a wide range of Russell indices, including the Russell 1000, 2500, 3000, Midcap and their associated value, dynamic and benchmark variants. This broad Russell index inclusion significantly increases CBC’s presence in institutional portfolios, as index-tracking funds may now allocate to the bank, potentially enhancing liquidity and visibility among investors. We’ll now examine how Central Bancompany’s broad Russell index...

Willis Towers Watson (NasdaqGS:WTW) appointed a new global leader for its Work & Rewards business, signaling a refresh in a key advisory unit. The company launched an art insurance facility for collectors and galleries in Asia through a partnership focused on regional specialty coverage. Insurtech firm Thimble adopted WTW’s Radar Live platform to support modernized pricing for commercial lines. WTW shares trade at $293.36, with a value score of 2 and a mixed return profile that includes a...

Wondering if Waste Management at around US$224.94 is priced for perfection or still has room on the upside? This article walks through the key signals that matter for value focused investors. The stock has seen a 4.7% decline over the last 7 days and a 2.3% decline over the last 30 days, while returns sit at 3.0% year to date and 0.6% over the past year, with longer term returns of 52.1% over 3 years and 88.1% over 5 years. Recent price moves sit against a backdrop of ongoing interest in...

If you are wondering whether Tenet Healthcare at around US$199.63 is still offering value or has already priced in its story, this breakdown is for you. The stock has recently seen a 5.7% decline over the last 7 days and a 13.2% decline over the last 30 days, while the 1 year return of 52.6% and very large 3 year and 5 year returns keep longer term holders focused. Recent headlines have focused on Tenet Healthcare as investors reassess hospital and healthcare operators, with attention on how...

Wondering if TransMedics Group at around US$108.92 is priced for its future potential or already reflecting high expectations? This article breaks down what the current share price might be implying about the company. The stock has seen a 12.7% decline over the past week and an 18.9% decline over the last 30 days, even though the 1 year return sits at 53.9% and the 3 year return at 45.8%. Recent coverage has focused on TransMedics Group's position in the medical technology space and what its...

If you are wondering whether Merit Medical Systems at around US$67.55 is starting to look appealing or still feels expensive, the recent share performance gives you a useful starting point. The stock has seen a 3.8% decline over the last 7 days, a 17.8% fall over the last 30 days, and is down 21.9% year to date and 35.5% over the past year, while the 5 year return stands at 13.4%. These moves have put more attention on how the market currently prices Merit Medical Systems and whether...

Over the last 7 days, the United States market has dropped 2.3%, yet it remains up by 13% over the past year with earnings forecasted to grow by 16% annually. In this context of fluctuating performance, identifying small-cap stocks with potential insider buying can be an intriguing strategy for investors seeking opportunities that may not be immediately apparent in larger market trends.

Over the last 7 days, the United States market has dropped 2.3%, but it has experienced a 13% rise over the past year, with earnings forecast to grow by 16% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong innovation and adaptability in an evolving market landscape.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks that are trading below their intrinsic value can present opportunities for investors seeking to capitalize on potential long-term gains amidst fluctuating market conditions.

The recent 13% drop in Indaptus Therapeutics, Inc.'s ( NASDAQ:INDP ) stock could come as a blow to insiders who...

Over the last 7 days, the United States market has dropped 2.3%, yet it has risen by 13% over the past year, with earnings forecasted to grow by 16% annually. In this context of fluctuating short-term performance and promising long-term growth prospects, stocks with high insider ownership can be particularly appealing as they often indicate confidence from those closest to the company's operations and future potential.

Sumitomo Mitsui Financial Group is reportedly exploring a potential takeover of Jefferies Financial Group, NYSE:JEF. Media reports indicate preliminary discussions and a gradual stake build since 2021, although no formal offer has been announced. Jefferies' management has publicly stated there are no active negotiations, keeping the situation in a speculative phase. For investors watching NYSE:JEF at a current share price of $40.55, the takeover speculation comes against a mixed performance...

Over the last 7 days, the U.S. market has dropped by 2.3%, though it has shown a robust increase of 13% over the past year, with earnings projected to grow by 16% annually in the coming years. In such fluctuating conditions, identifying stocks with strong fundamentals and solid balance sheets can be crucial for investors seeking growth opportunities at lower price points. Penny stocks, often representing smaller or newer companies, continue to present underappreciated potential for growth and...

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it remains up by 13% over the past year with earnings projected to grow by 16% annually. In this context, identifying stocks with strong fundamentals and growth potential can be key to uncovering promising opportunities in an evolving market landscape.

Over the last 7 days, the United States market has experienced a 2.3% drop, yet it has shown resilience with a 13% rise over the past year and earnings are expected to grow by 16% annually. In such dynamic conditions, dividend stocks can offer investors stability and income potential, making them an attractive option for those seeking steady returns amidst market fluctuations.

Insiders who bought US$1.73m worth of Cartesian Therapeutics, Inc.'s ( NASDAQ:RNAC ) stock at an average buy price of...